- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0191633

Dapica Pharmaceuticals Private Limited
About Dapica Pharmaceuticals Private Limited
Data last updated:
Dapica Pharmaceuticals Private Limited is a private limited company based in Badlapur, Maharashtra, India. It operates in the household goods segment of the home appliances and consumer durables sector. It was incorporated on 23 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2021PTC372021.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Dharmnarayan Mishra and Priyanka Amit Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 102 G – Wing Tulsi Aahan Opp Essar Petrol P. Ambarnath, Badlapur, Maharashtra, India – 421503.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.61 Lakh, a growth of 99% compared to the previous year. For the same year it recorded a net loss of ₹2.86 Lakh (net margin -24.6%) and EBITDA of -₹2.62 Lakh (EBITDA margin -22.6%).
As per MCA filings, the company has open charges of ₹3 Lakh on record.
Dapica Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0191633).
Company details
Recognitions & Rankings of Dapica Pharmaceuticals
Contact details
Dapica Pharmaceuticals Private Limited's registered office is in Badlapur, Maharashtra.
- Registered AddressFlat No. 102 G – Wing Tulsi Aahan Opp Essar Petrol P. Ambarnath, Badlapur, Maharashtra, India – 421503
- IndustryHome Appliances, Household Goods, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dapica Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Dapica Pharmaceuticals Private Limited, buy the company report.
Financials of Dapica Pharmaceuticals Private Limited
FY 2025 filings availableDapica Pharmaceuticals Private Limited reported revenue of ₹11.61 Lakh (up 99% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2.62 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2.86 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -22.6% | |||
| Net Profit Margin | -24.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dapica Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dapica Pharmaceuticals Private Limited
Dapica Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Dharmnarayan Mishra | Director | 23 Nov 2021 | 4 Years 11 Months | Current |
| Priyanka Amit Mishra | Director | 23 Nov 2021 | 4 Years 11 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2024 | 101037217 | Canara Bank | ₹3 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dapica Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dapica Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dapica Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dapica Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Amit Dharmnarayan Mishra was appointed as Director on 23 Nov 2021.
Frequently asked questions
Dapica Pharmaceuticals is an active private limited company based in Badlapur, Maharashtra, India. The company works in household goods, within the home appliances industry. It was incorporated on 23 November 2021 (5+ years old) and is registered under CIN U51397MH2021PTC372021.
Dapica Pharmaceuticals has 2 current directors:
- Amit Dharmnarayan Mishra - Director
- Priyanka Amit Mishra - Director
The latest financial statements of Dapica Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Dapica Pharmaceuticals is U51397MH2021PTC372021. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dapica Pharmaceuticals was incorporated on 23 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Amit Dharmnarayan Mishra was appointed as Director on 23 Nov 2021. Priyanka Amit Mishra was appointed as Director on 23 Nov 2021.
Yes, Dapica Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0191633).
The registered office of Dapica Pharmaceuticals is at Flat No. 102 G – Wing Tulsi Aahan Opp Essar Petrol P. Ambarnath, Badlapur, Maharashtra, India – 421503.
Dapica Pharmaceuticals operates in the home appliances industry, in the household goods segment.
Dapica Pharmaceuticals has open charges of ₹3 Lakh and no satisfied charges on record as per latest MCA filings.

